Janssen Submits Additional Marketing Applications for ZYTIGA In the U.S. and European Union – The FINANCIAL

Both applications are intended to extend the use of ZYTIGA administered with prednisone to include the treatment of patients with metastatic castration-resistant prostate cancer who are asymptomatic or mildly symptomatic after failure of androgen …